Geri
Unicycive Therapeutics Inc (UNCY) Kazanmak
UNCY Hisse Senedi Fiyat Grafiği
UNCY Kazanmak
Unicycive Therapeutics Inc
$6.93
-2.66%
$-0.19
Kapanışta: Apr 02, 16:00:00 GMT-4
$7
1.14%
$0.07
Sonrası Piyasa: Apr 02, 20:00:00 GMT-4
Önemli İstatistikler
Önceki Kapanış
$7.12
Açılış fiyatı
$6.99
Günün Aralığı
$6.76 - $7.08
52 haftalık aralık
$3.71 - $11
İşlem hacmi
487.4K
Ort.Hacim
558.2K
Dividend yield
--
EPS (TTM)
-2.97
Piyasa Değeri
$150.6M
UNCY nedir?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.